Short- and medium-chain fatty acids in energy metabolism: The cellular perspective

Journal of Lipid Research

Volumn 57, Issue 6, 2016, Pages 943-954

  Schönfeld, Peter ^a,b   Wojtczak, Lech ^c  

^a UNIVERSITY OF WARSAW   (Poland)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

Long chain fatty acids; Mitochondria; Short chain fatty acids

Indexed keywords

ACETIC ACID; BUTYRIC ACID; CARBOHYDRATE; CARNITINE; DECANOIC ACID; FATTY ACID BINDING PROTEIN; FORMIC ACID; HEXANOIC ACID; LAURIC ACID; LIPID; MEDIUM CHAIN FATTY ACID; NONANOIC ACID; OCTANOIC ACID; PALMITOYL COENZYME A HYDROLASE; PROPIONIC ACID; REACTIVE OXYGEN METABOLITE; SHORT CHAIN FATTY ACID; TRIACYLGLYCEROL; UNDECANOIC ACID; VALERIC ACID; ACYL COENZYME A; ADENOSINE TRIPHOSPHATE; FATTY ACID;

CARBOHYDRATE METABOLISM; CELL METABOLISM; COLON FLORA; DAIRY PRODUCT; ELECTRON TRANSPORT; ENERGY METABOLISM; GLUCONEOGENESIS; GLYCOLYSIS; HUMAN; INTESTINE CELL; LIPID METABOLISM; LIPOGENESIS; LIVER; MILK; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY CHAIN; REVIEW; SIGNAL TRANSDUCTION; TISSUE METABOLISM; BIOSYNTHESIS; METABOLISM; OXIDATION REDUCTION REACTION;

ACYL COENZYME A; ADENOSINE TRIPHOSPHATE; CARNITINE; ENERGY METABOLISM; FATTY ACIDS; HUMANS; MITOCHONDRIA; OXIDATION-REDUCTION; TRIGLYCERIDES;

EID: 84971510696     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R067629     Document Type: Review

References (161)

1. Marten, B., M. Pfeuffer, and J. Schrezenmeir. 2006. Mediumchain triglycerides. Int. Dairy J. 16: 1374-1382.
2. Cummings, J. H., E. W. J. Pomare, H. W. J. Branch, C. P. E. Naylor, and G. T. MacFarlane. 1987. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 28: 1221-1227.
3. Wong, J. M., R. de Souza, C. W. Kendall, A. Emam, and D. J. Jenkins. 2006. Colonic health: fermentation and short chain fatty acids. J. Clin. Gastroenterol. 40: 235-243.
4. Bergman, E. N. 1990. Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol. Rev. 70: 567-590.
5. Trock, B., E. Lanza, and P. Greenwald. 1990. Dietary fiber, vegetables, and colon cancer: critical review and meta-analyses of the epidemiologic evidence. J. Natl. Cancer Inst. 82: 650-661.
6. Hague, A., D. J. Elder, D. J. Hicks, and C. Paraskeva. 1995. Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int. J. Cancer. 60: 400-406.
7. Tan, J., C. McKenzie, M. Potamitis, A. N. Thorburn, C. R. Mackay, and L. Macia. 2014. The role of short-chain fatty acids in health and disease. Adv. Immunol. 121: 91-119.
8. Liberato, M. V., A. S. Nascimento, S. D. Ayers, J. Z. Lin, A. Cvoro, R. L. Silveira, L. Martínez, P. C. Souza, D. Saidemberg, T. Deng, et al. 2012. Medium chain fatty acids are selective peroxisome proliferator activated receptor (PPAR)γ activators and pan-PPAR partial agonists. PLoS One. 7: e36297.
9. Byrne, C. S., E. S. Chambers, D. J. Morrison, and G. Frost. 2015. The role of short chain fatty acids in appetite regulation and energy homeostasis. Int. J. Obes. (Lond). 39: 1331-1338.
10. Bäckhed, F., H. Ding, T. Wang, L. V. Hooper, G. Y. Koh, A. Nagy, C. F. Semenkovich, and J. L. Gordon. 2004. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA. 101: 15718-15723.
11. Ramakrishna, B. S. 2013. Role of the gut microbiota in human nutrition and metabolism. J. Gastroenterol. Hepatol. 28(Suppl. 4): 9-17.
12. Georgiadi, A., and S. Kersten. 2012. Mechanism of gene regulation by fatty acids. Adv. Nutr. 3: 127-134.
13. Poulsen, L., M. Siersbæk, and S. Mandrup. 2012. PPARs: fatty acid sensors controlling metabolism. Semin. Cell Dev. Biol. 23: 631-639.
14. Nakamura, M. T., B. E. Yudell, and J. J. Loor. 2014. Regulation of the energy metabolism by long-chain fatty acid. Prog. Lipid Res. 53: 124-144.
15. Hara, T., I. Kimura, D. Inoue, A. Ichimura, and A. Hirasawa. 2013. Free fatty acid receptors and their role in regulation of energy metabolism. Rev. Physiol. Biochem. Pharmacol. 164: 77-116.
16. Hara, T., D. Kashihara, A. Ichimura, I. Kimura, G. Tsujimoto, and A. Hirasawa. 2014. Role of free fatty acid receptors in the regulation of energy metabolism. Biochim. Biophys. Acta. 1841: 1292-1300.
17. Chen, J. S., D. V. Faller, and R. A. Spanjaard. 2003. Short-chain fatty acid inhibitors of histone deacetylases: promising anticancer therapeutics? Curr. Cancer Drug Targets. 3: 219-236.
18. Tang, Y., Y. Chen, H. Jiang, and D. Nie. 2011. Short-chain fatty acids induced autophagy serves as an adaptive strategy for retarding mitochondria-mediated apoptotic cell death. Cell Death Differ. 18: 602-618.
19. Fauser, J. K., G. M. Matthew, A. G. Cummins, and G. S. Howart. 2013. Induction of apoptosis by the medium-chain length fatty acid lauric acid in colon cancer cells due to induction of oxidative stress. Chemotherapy. 59: 214-224.
20. Walsh, M. E., A. Bhattacharya, K. Sataranataran, R. Qaisar, L. Sloane, M. M. Rahman, M. Kinter, and H. van Remmen. 2015. The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging. Aging Cell. 14: 957-970.
21. Bach, A. C., and V. K. Babayan. 1982. Medium-chain triglycerides: an update. Am. J. Clin. Nutr. 36: 950-962.
22. Papamandjaris, A. A., D. E. MacDougall, and P. J. H. Jones. 1998. Medium chain fatty acid metabolism and energy expenditure: obesity treatment implications. Life Sci. 62: 1203-1215.
23. Wojtczak, L., and P. Schönfeld. 1993. Effect of fatty acids on the energy coupling processes in mitochondria. Biochim. Biophys. Acta. 1183: 41-57.
24. Spector, A. A., and M. A. Yorek. 1985. Membrane lipid composition and cellular function. J. Lipid Res. 26: 1015-1035.
25. Seidelin, K. N. 1995. Fatty acid composition of adipose tissue in humans. Implications for the dietary fat-serum cholesterol-CHD issue. Prog. Lipid Res. 34: 199-217.
26. Rauen, H. M. 1964. Biochemisches Taschenbuch. Springer, Berlin-Göttingen-Heidelberg.
27. Mukerjee, P. 1965. Dimerization of anions of long-chain fatty acids in aqueous solutions and the hydrophobic properties of the acids. J. Phys. Chem. 69: 2821-2827.
28. Smith, R., and C. Tanford. 1973. Hydrophobicity of long chain n-alkyl carboxylic acids as measured by their distribution between heptane and aqueous solutions. Proc. Natl. Acad. Sci. USA. 70: 289-293.
29. Evtodienko, V. Y., O. N. Kovbasnjuk, Y. N. Antonenko, and L. S. Yaguzhinsky. 1996. Effect of the alkyl chain length of monocarboxylic acid on the permeation through bilayer lipid membranes. Biochim. Biophys. Acta. 1281: 245-251.
30. Kamp, F., and J. A. Hamilton. 2006. How fatty acids of different chain length enter and leave cells by free diffusion. Prostaglandins Leukot. Essent. Fatty Acids. 75: 149-159.
31. Apel, C. L., D. W. Deamer, and M. N. Mautner. 2002. Selfassembled vesicles of monocarboxylic acids and alcohols: conditions for stability and for encapsulation of biopolymers. Biochim. Biophys. Acta. 1559: 1-9.
32. Small, D. M., D. J. Cabral, D. P. Cistola, J. S. Parks, and J. A. Hamilton. 1984. The ionization behavior of fatty acids and bile acids in micelles and membranes. Hepatology. 4(Suppl): 77S-79S.
33. Lieckfeldt, R., J. Villalaín, J. C. Gómez-Fernández, and G. Lee. 1995. Apparent pKa of the fatty acids within ordered mixtures of model human stratum corneum lipids. Pharm. Res. 12: 1614-1617.
34. Miller, T. L., and M. J. Wolin. 1996. Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora. Appl. Environ. Microbiol. 62: 1589-1592.
35. Schweiger, G., and W. Buckel. 1984. On the dehydration of (R)-lactate in the fermentation of alanine to propionate by Clostridium propionicum. FEBS Lett. 171: 79-84.
36. Counotte, G. H., R. A. Prins, R. H. A. M. Janssen, and M. J. A. Debie. 1981. Role of Megasphaera elsdenii in the fermentation of dl-[2-C]lactate in the rumen of dairy cattle. Appl. Environ. Microbiol. 42: 649-655.
37. Pryde, S. E., S. H. Duncan, G. L. Hold, C. S. Stewart, and H. J. Flint. 2002. The microbiology of butyrate formation in the human colon. FEMS Microbiol. Lett. 217: 133-139.
38. Cummings, J. H., M. J. Hill, E. S. Bone, W. J. Branch, and D. J. Jenkins. 1979. The effect of meat protein and dietary fiber on colonic function and metabolism. II. Bacterial metabolites in feces and urine. Am. J. Clin. Nutr. 32: 2094-2101.
39. Tazoe, H., Y. Otomo, I. Kaji, R. Tanaka, S. I. Karaki, and A. Kuwahara. 2008. Roles of short-chain fatty acid receptors, GPR41 and GPR43, on colonic functions. J. Physiol. Pharmacol. 59(Suppl. 2): 251-262.
40. Bloemen, J. G., K. Venema, M. C. van de Poll, S. W. Olde Damink, W. A. Buurman, and C. H. Dejong. 2009. Short chain fatty acids exchange across the gut and the liver in humans measured at surgery. Clin. Nutr. 28: 657-661.
41. van Beusekom, C., I. A. Martini, H. M. Rutgers, E. R. Boersma, and F. A. Muskiet. 1990. A carbohydrate-rich diet not only leads to incorporation of medium-chain fatty acids (6:0-14:0) in milk triglycerides but also in each milk-phospholipid subclass. Am. J. Clin. Nutr. 52: 326-334.
42. Bahrami, G., and Z. Rahimi. 2005. Fatty acid composition of human milk in Western Iran. Eur. J. Clin. Nutr. 59: 494-497.
43. Masters, C., and D. Crane. 1996. The peroxisome. In Principles of Medical Biology. Vol. 3. E. E. Bittar and N. Bittar, editors. Elsevier, Amsterdam. 39-58.
44. Hunt, M. C., M. I. Siponen, and S. H. E. Alexson. 2012. The emerging role of acyl-CoA thioesterases and acyltransferases in regulating peroxisomal lipid metabolism. Biochim. Biophys. Acta. 1822: 1397-1410.
45. Onkenhout, W., V. Venizelos, P. F. H. van der Poel, M. P. M. van den Heuvel, and B. J. H. M. Poorthuis. 1995. Identification and quantification of intermediates of unsaturated fatty acid metabolism in plasma of patients with fatty acid oxidation disorders. Clin. Chem. 41: 1467-1474.
46. Scaini, G., K. R. Simon, A. M. Tonin, E. N. Busanello, A. O. Moura, G. C. Ferreira, M. Wajner, E. L. Streck, and P. F. Schuck. 2012. Toxicity of octanoate and decanoate in rat peripheral tissues: evidence of bioenergetic dysfunction and oxidative damage induction in liver and skeletal muscle. Mol. Cell. Biochem. 361: 329-335.
47. Gregersen, N., P. B. Mortensen, and S. Kølvraa. 1983. On the biologic origin of C6-C10-dicarboxylic C6-C10-ω-1-hydroxy monocarboxylic acids in human and rat with acyl-CoA dehydrogenation deficiencies: in vitro studies on the ω- and ω-1-oxidation of medium-chain (C6-C12) fatty acids in human and rat liver. Pediatr. Res. 17: 828-834.
48. Gregersen, N. 1985. The acyl-CoA dehydrogenation deficiencies. Recent advances in the enzymic characterization and understanding of the metabolic and pathophysiological disturbances in patients with acyl-CoA dehydrogenation deficiencies. Scand. J. Clin. Lab. Invest. Suppl. 174: 1-60.
49. Grattagliano, I., B. H. Lautenburg, G. Palasciano, and P. Portincasa. 2010.13 C-Breath tests for clinical investigation of liver mitochondrial function. Eur. J. Clin. Invest. 40: 843-850.
50. Bruno, G., L. R. Lopetuso, G. Ianiro, L. Laterza, V. Gerardi, V. Petito, A. Poscia, A. Gasbarrini, V. Ojetti, and F. Scaldafferri. 2013. 13C-Octanoic acid breath test to study gastric emptying time. Eur. Rev. Med. Pharmacol. Sci. 17(Suppl. 2): 59-64.
51. Bonfrate, L., I. Grattagliano, G. Palsciano, and P. Portincasa. 2015. Dynamic carbon 13 breath tests for the study of liver function and gastric emptying. Gastroenterol. Rep. (Oxf.). 3: 12-21.
52. Enerson, B. E., and L. R. Drewes. 2003. Molecular features, regulation, and function of monocarboxylate transporters: implications for drug delivery. J. Pharm. Sci. 92: 1531-1544.
53. Gonçalves, P., and F. Martel. 2013. Butyrate and colorectal cancer: the role of butyrate transport. Curr. Drug Metab. 14: 994-1008.
54. Rajendran, V. M., and H. J. Binder. 1994. Apical membrane Clbutyrate exchange mechanism of short chain fatty acid stimulation of active chloride absorption in rat distal colon. J. Membr. Biol. 141: 51-58.
55. Mascolo, N., V. M. Rajendran, and H. J. Binder. 1991. Mechanism of short-chain fatty acid uptake by apical membrane vesicles of rat distal colon. Gastroenterology. 101: 331-338.
56. Charney, A. N., L. Micic, and R. W. Egnor. 1998. Nonionic diffusion of short-chain fatty acids across rat colon. Am. J. Physiol. 274: G518-G524.
57. Sellin, J. H., and R. DeSoignie. 1990. Short-chain fatty acid absorption in the human colon in vitro. Gastroenterology. 99: 676-683.
58. Demigné, C., C. Yacoub, and C. Rémésy. 1986. Effects of absorption of large amounts of volatile fatty acids on rat liver metabolism. J. Nutr. 116: 77-86.
59. Ashbrook, J. D., A. A. Spector, and J. E. Fletcher. 1972. Medium chain fatty acid binding to human plasma albumin. J. Biol. Chem. 247: 7038-7042.
60. Ashbrook, J. D., A. A. Spector, E. C. Santos, and J. E. Fletcher. 1975. Long chain fatty acid binding to human plasma albumin. J. Biol. Chem. 250: 2333-2338.
61. Pégorier, J. P., P. H. Duée, C. Herbin, P. Y. Laulan, C. Bladée, J. Peret, and J. Girard. 1988. Fatty acid metabolism in hepatocytes isolated from rats adapted to high-fat diets containing long- or medium-chain triacylglycerols. Biochem. J. 249: 801-806.
62. Ishizawa, R., K. Masuda, S. Sakata, and A. Nakatani. 2015. Effects of different fatty acid chain lengths on fatty acid oxidation-related protein expression levels in rat skeletal muscles. J. Oleo Sci. 64: 415-421.
63. Atshaves, B. P., G. G. Martin, H. A. Hostetler, A. L. McIntosh, A. B. Kier, and F. Schroeder. 2010. Liver fatty acid-binding proteins and obesity. J. Nutr. Biochem. 21: 1015-1032.
64. Hajri, T., A. Ibrahimi, C. T. Coburn, F. F. Knapp, Jr., T. Kurtz, M. Praveneci, and N. A. Abumrad. 2001. Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy. J. Biol. Chem. 276: 23661-23666.
65. Irie, H., I. B. Krukenkamp, J. F. F. Brinkmann, G. R. Gaudette, A. E. Saltman, W. Jou, J. F. C. Glatz, N. A. Abumrad, and A. Ibrahimi. 2003. Myocardial recovery from ischemia is impaired in CD36-null mice and restored by myocyte CD36 expression or medium-chain fatty acids. Proc. Natl. Acad. Sci. USA. 100: 6819-6824.
66. Lundquist, F., N. Tygstrup, K. Winkler, K. Mellemgaard, and S. Munck-Petersen. 1962. Ethanol metabolism and production of free acetate in the human liver. J. Clin. Invest. 41: 955-961.
67. Lundquist, F. 1960. The concentration of acetate in blood during alcohol metabolism in man. Acta Physiol. Scand. 175: 97-105.
68. Seufert, C. D., M. Graf, G. Janson, A. Kuhn, and H. D. Söling. 1974. Formation of free acetate by isolated perfused livers from normal, starved and diabetic rats. Biochem. Biophys. Res. Commun. 57: 901-909.
69. Grigat, K. P., K. Koppe, C. D. Seufert, and H. D. Söling. 1979. Acetyl-coenzyme A deacylase activity in liver is not an artefact. Subcellular distribution and substrate specificity of acetyl-coenzyme A deacylase activities in rat liver. Biochem. J. 177: 71-79.
70. Yamashita, H., T. Kaneyuki, and K. Tagawa. 2001. Production of acetate in the liver and its utilization in peripheral tissues. Biochim. Biophys. Acta. 1532: 79-87.
71. Groot, P. H. E. 1975. The activation of short-chain fatty acids by the soluble fraction of guinea-pig heart and liver mitochondria. The search for distinct propionyl-CoA synthase. Biochim. Biophys. Acta. 380: 12-20.
72. Scholte, H. R., and P. H. E. Groot. 1975. Organ and intracellular localization of short-chain acyl-CoA synthetases in rat and guineapig. Biochim. Biophys. Acta. 409: 283-296.
73. Fujino, T., J. Kondo, M. Ishikawa, K. Morikawa, and T. T. Yamamoto. 2001. Acetyl-CoA synthase 2, a mitochondrial matrix enzyme involved in the oxidation of acetate. J. Biol. Chem. 276: 11420-11426.
74. Barth, C., M. Sladek, and K. Decker. 1971. The subcellular distribution of short-chain acyl-CoA synthetase activity in rat tissues. Biochim. Biophys. Acta. 248: 24-33.
75. Goldberg, R. P., and H. Brunengraber. 1980. Contribution of cytosolic and mitochondrial acetyl-CoA synthetases to the activation of lipogenic acetate in rat liver. Adv. Exp. Med. Biol. 132: 413-418.
76. Endemann, G., P. G. Goetz, J. F. Tomera, W. M. Rand, S. Desrochers, and H. Brunengraber. 1987. Lipogenesis from ketone bodies in the perfused rat liver: effects of acetate and ethanol. Biochem. Cell Biol. 65: 989-996.
77. Sakakibara, I., T. Fujino, M. Ishii, T. Tanaka, T. Shimosawa, S. Miura, W. Zhang, Y. Tokutake, J. Yamamoto, M. Awano, et al. 2009. Fasting-induced hypothermia and reduced energy production in mice lacking acetyl-CoA synthetase 2. Cell Metab. 9: 191-202.
78. Shimazu, T., M. D. Hirschey, J-Y. Huang, L. T. Y. Ho, and E. Verdin. 2010. Acetate metabolism and aging: An emerging connection. Mech. Ageing Dev. 131: 511-516.
79. Aas, M., and J. Bremer. 1968. Short-chain fatty acid activation in rat liver. A new assay procedure for the enzymes and studies on their intracellular localization. Biochim. Biophys. Acta. 164: 157-166.
80. Vessey, D. A., M. Kelley, and R. S. Warren. 1999. Characterization of the CoA ligases of human liver mitochondria catalyzing the activation of short- and medium-chain fatty acids and xenobiotic carboxylic acids. Biochim. Biophys. Acta. 1428: 455-462.
81. Boomgaarden, I., C. Vock, M. Klapper, and F. Döring. 2009. Comparative analyses of disease risk genes belonging to the acyl-CoA synthetase medium-chain (ACSM) family in human liver and cell lines. Biochem. Genet. 47: 739-748.
82. Kasumov, T., J. E. Adamas, F. Bian, F. David, K. R. Thomas, K. A. Jobbins, P. E. Minkler, C. L. Hoppel, and H. Brunengraber. 2005. Probing peroxisomal β-oxidation and the labelling of acetyl-CoA proxies with [1-13 C]octanoate and [3-13 C]octanoate in the perfused rat liver. Biochem. J. 389: 397-401.
83. Bian, F., T. Kasumov, K. R. Thomas, K. A. Jobbins, F. David, P. E. Minkler, C. L. Hoppel, and H. Brunengraber. 2005. Peroxisomal and mitochondrial oxidation of fatty acids in the heart, assessed from the13C labeling of malonyl-CoA and the acetyl moiety of citrate. J. Biol. Chem. 280: 9265-9271.
84. Jeppesen, P. B., and P. B. Mortensen. 1999. Colonic digestion and absorption of energy from carbohydrates and medium-chain fat in small bowel failure. JPEN J. Parenter. Enteral Nutr. 23: S101-S105.
85. Hecker, M., N. Sommer, H. Voigtmann, O. Pal, A. Mor, M. Wolf, I. Vadasz, S. Herold, N. Weissmann, R. E. Morty, et al. 2014. Impact of short- and medium-chain fatty acids on mitochondrial function in severe inflammation. JPEN J. Parenter. Enteral Nutr. 38: 587-594.
86. Zurier, R. B., R. G. Campbell, S. A. Hashim, and T. B. van Itallie. 1967. Enrichment of depot fat with odd and even numbered medium chain fatty acids. Am. J. Physiol. 212: 291-294.
87. Labarthe, F., R. Gélinas, and C. Des Rosiers. 2008. Medium-chain fatty acids as metabolic therapy in cardiac disease. Cardiovasc. Drugs Ther. 22: 97-106.
88. Lemarié, F., E. Beauchamp, P. Legrand, and V. Rioux. 2016. Revisiting the metabolism and physiological functions of caprylic acid (C8:0) with special focus on ghrelin octanoylation. Biochimie. 120: 40-48.
89. Debeer, L. J., G. Mannaerts, and P. J. de Scheppe. 1974. Effects of octanoate and oleate on energy metabolism in the perfused rat liver. Eur. J. Biochem. 47: 591-600.
90. Kingsley-Hickman, P. B., E. Y. Sako, K. Uǧurbil, A. H. L. From, and J. E. Foker. 1990.31 P NMR measurement of mitochondrial uncoupling in isolated rat hearts. J. Biol. Chem. 265: 1545-1550.
91. Scholz, R., U. Schwabe, and S. Soboll. 1984. Influence of fatty acids on energy metabolism. 1. Stimulation of oxygen consumption, ketogenesis and CO2 production following addition of octanoate and oleate in perfused rat liver. Eur. J. Biochem. 141: 223-230.
92. Soboll, S., S. Gründel, and R. Scholz. 1984. Influence of fatty acids on energy metabolism. 2. Kinetics of changes in metabolic rates and changes in subcellular adenine nucleotide contents and pH gradients following addition of octanoate and oleate in perfused rat liver. Eur. J. Biochem. 141: 231-236.
93. Walton, M. E., D. Ebert, and R. G. Haller. 2003. Octanoate oxidation measured by 13 C-NMR spectroscopy in rat skeletal muscle, heart, and liver. J. Appl. Physiol. 95: 1908-1916.
94. Ebert, D., R. G. Haller, and M. E. Walton. 2003. Energy contribution of octanoate to intact rat brain metabolism measured by13 C nuclear magnetic resonance spectroscopy. J. Neurosci. 23: 5928-5935.
95. Spector, R. 1988. Fatty acid transport through the blood-brain barrier. J. Neurochem. 50: 639-643.
96. Beauvieux, M-C., P. Tissier, H. Gin, P. Canioni, and J-L. Gallis. 2001. Butyrate impairs energy metabolism in isolated perfused liver of fed rats. J. Nutr. 131: 1986-1992.
97. Gallis, J-L., P. Tissier, H. Gin, and M-C. Beauvieux. 2007. Decrease in oxidative phosphorylation yield in presence of butyrate in perfused liver isolated from fed rats. BMC Physiol. 7: 8.
98. Gallis, J-L., H. Gin, H. Roumes, and M-C. Beauvieux. 2011. A metabolic link between mitochondrial ATP synthesis and liver glycogen metabolism: NMR study in rats re-fed with butyrate and/or glucose. Nutr. Metab. (Lond). 8: 38.
99. Plomp, P. J. A. M., C. W. T. van Roermund, A. K. Groon, A. J. Meijer, and J. M. Tager. 1985. Mechanism of the stimulation of respiration by fatty acids in rat liver. FEBS Lett. 193: 243-246.
100. Schönfeld, P., A. B. Wojtczak, M. J. H. Geelen, W. Kunz, and L. Wojtczak. 1988. On the mechanism of the so-called uncoupling effect of medium- and short-chain fatty acids. Biochim. Biophys. Acta. 936: 280-288.
101. Nobes, C. D., W. W. Hay, Jr., and M. D. Brand. 1990. The mechanism of stimulation of respiration by fatty acids in isolated hepatocytes. J. Biol. Chem. 265: 12910-12915.
102. Hassinen, I., K. Ito, S. Nioka, and B. Chance. 1990. Mechanism of fatty acid effect on myocardial oxygen consumption. A phosphorus NMR study. Biochim. Biophys. Acta. 1019: 73-80.
103. Turner, N., K. Hariharan, J. TidAng, G. Frangioudakis, S. M. Beale, L. E. Wright, X. Y. Zeng, S. J. Leslie, J. Y. Li, E. W. Kraegen, et al. 2009. Enhancement of muscle mitochondrial oxidative capacity and alterations in insulin action are lipid species dependent: potent tissue-specific effects of medium-chain fatty acids. Diabetes. 58: 2547-2554.
104. Saudubray, J. M., D. E. Martin, P. de Lonlay, G. Touati, F. Poggi-Travert, D. Bonnet, P. Jouvet, M. Boutron, A. Slama, C. Vianey-Saban, et al. 1999. Recognition and management of fatty acid oxidation defects: a series of 107 patients. J. Inherit. Metab. Dis. 22: 488-502.
105. Roe, C. R., L. Sweetman, D. S. Roe, F. David, and H. Brunengraber. 2002. Treatment of cardiomyopathy and rhabdomyolysis in longchain fat oxidation disorders using an anaplerotic odd-chain triglyceride. J. Clin. Invest. 110: 259-269.
106. Metges, C. C., and G. Wolfram. 1991. Medium- and long-chain triglycerides labelled with 13 C: A comparison of oxidation after oral or parenteral administration in humans. J. Nutr. 121: 31-36.
107. Nomura, T., A. Iguchi, N. Sakamoto, and R. A. Harris. 1983. Effects of octanoate and acetate upon hepatic glycolysis and lipogenesis. Biochim. Biophys. Acta. 754: 315-320.
108. Morand, C., C. Besson, C. Demigne, and C. Remesy. 1994. Importance of the modulation of glycolysis in the control of lactate metabolism by fatty acids in isolated hepatocytes from fed rats. Arch. Biochem. Biophys. 309: 254-260.
109. González-Manchón, C., M. S. Ayuso, and R. Parrilla. 1989. Control of hepatic gluconeogenesis: Role of fatty acid oxidation. Arch. Biochem. Biophys. 271: 1-9.
110. Winiarska, K., J. Dro¿ak, M. Wȩgrzynowicz, A. K. Jagielski, and J. Bryła. 2003. Relationship between gluconeogenesis and glutathione redox state in rabbit kidney-cortex tubules. Metabolism. 52: 739-746.
111. Agius, L., and G. M. M. Alberti. 1985. Regulation of flux through pyruvate dehydrogenase and pyruvate carboxylase in rat hepatocytes. Eur. J. Biochem. 152: 699-707.
112. Geelen, M. J. 1994. Medium-chain fatty acids as short-term regulators of hepatic lipogenesis. Biochem. J. 302: 141-146.
113. Thevenet, J., U. DeMarchi, J. S. Domingo, N. Christinat, L. Bultot, G. Lefebvre, K. Sakamoto, P. Descombes, M. Masoodi, and A. Wiederkehr. Medium-chain fatty acids inhibit mitochondrial metabolism in astrocytes promoting astrocyte-neuron lactate and ketone body shuttle systems. FASEB J. Epub ahead of print. February 2, 2016; doi:10.1096/fj.201500182.
114. Williamson, J. R., E. T. Browing, and M. S. Olson. 1968. Interrelationships between fatty acid oxidation and the control of gluconeogenesis in perfused rat liver. Adv. Enzyme Regul. 6: 67-100.
115. Hu, G-X., G-R. Chen, H. Xu, R-S. Ge, and J. Lin. 2010. Activation of the AMP activated protein kinase by short-chain fatty acids is the main mechanism underlying the beneficial effect of a high fiber diet on the metabolic syndrome. Med. Hypotheses. 74: 123-126.
116. Takikawa, M., A. Kumagai, H. Hirata, M. Soga, Y. Yamashita, M. Ueda, H. Ashida, and T. Tsuda. 2013. 10-Hydroxy-2-decenoic acid, a unique medium-chain fatty acid, activates 5?-AMP-activated protein kinase in L6 myotubes and mice. Mol. Nutr. Food Res. 57: 1794-1802.
117. Guo, W., T. Lei, B. E. Corkey, and J. Han. 2003. Octanoate inhibits triglyceride synthesis in 3T3-LI and human adipocytes. J. Nutr. 133: 2512-2518.
118. Beauvieux, M. C., H. Roumes, N. Robert, H. Gin, V. Rigalleau, and J. L. Gallis. 2008. Butyrate ingestion improves hepatic glycogen storage in the re-fed rat. BMC Physiol. 8: 19.
119. Okere, I. C., T. A. McElfresh, D. Z. Brunengraber, W. Martini, J. P. Sterk, H. Huang, M. P. Chandler, H. Brunengraber, and W. C. Stanley. 2006. Differential effects of heptanoate and hexanoate on myocardial citric acid cycle intermediates following ischemiareperfusion. J. Appl. Physiol. 100: 76-82.
120. Kajimoto, M., D. R. Ledee, A. K. Olson, N. G. Isern, C. Des Rosiers, and M. P. Portman. 2015. Differential effects of octanoate and heptanoate on myocardial metabolism during extracorporal membrane oxygenation in infant swine model. Am. J. Physiol. Heart Circ. Physiol. 309: H1157-H1165.
121. Brunengraber, H., and C. R. Roe. 2006. Anaplerotic molecules: current and Future. J. Inherit. Metab. Dis. 29: 327-331.
122. Marin-Valencia, I., L. B. Good, Q. Ma, C. R. Malloy, and J. M. Pascual. 2013. Heptanoate as neural fuel: energetic and neurotransmitter precursors in normal and glucose transporter I-deficient (G1D) brain. J. Cereb. Blood Flow Metab. 33: 175-182.
123. Mochel, F., P. DeLonlay, G. Touati, H. Brunengraber, R. P. Kinman, D. Rabier, C. R. Roe, and J. M. Saudubray. 2005. Pyruvate carboxylase deficiency: clinical and biochemical response to anaplerotic diet therapy. Mol. Genet. Metab. 84: 305-312.
124. Willis, S., J. Stoll, L. Sweetman, and K. Borges. 2010. Anticonvulsant effects of triheptanoin diet in two mouse chronic seizure models. Neurobiol. Dis. 40: 565-572.
125. Borges, K., and U. Sonnewald. 2012. Triheptanoin-a mediumchain triglyceride with odd chain fatty acids: a new anaperotic anticonvulsant treatment. Epilepsy Res. 100: 239-244.
126. Hadera, M. G., O. B. Smeland, T. S. McDonald, K. Ni Tan, U. Sonnewald, and K. Borges. 2014. Triheptanoin partially restores levels of tricarboxylic cycle intermediates in the mouse pilocarpine model of epilepsy. J. Neurochem. 129: 107-119.
127. Schwarzkopf, T. M., K. Koch, and J. Klein. 2015. Reduced severity of ischemic stroke and improvement of mitochondrial function after dietary treatment with the anaplerotic substance triheptanoin. Neuroscience. 300: 201-209.
128. Al-Lahham, S. H., M. P. Peppelenbosch, H. Roelofsen, R. J. Vonk, and K. Venema. 2010. Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim. Biophys. Acta. 1801: 1175-1183.
129. Skulachev, V. P. 1991. Fatty acid circuit as a physiological mechanism of uncoupling of oxidative phosphorylation. FEBS Lett. 294: 158-162.
130. Skulachev, V. P. 1999. Anion carriers in fatty acid-mediated physiological uncoupling. J. Bioenerg. Biomembr. 31: 431-445.
131. Wojtczak, L., and M. R. Wiȩckowski. 1999. The mechanisms of fatty acid-induced proton permeability of the inner mitochondrial membrane. J. Bioenerg. Biomembr. 31: 447-455.
132. Bernardi, P., D. Penzo, and L. Wojtczak. 2002. Mitochondrial energy dissipation by fatty acids: Mechanisms and implications for cell death. Vitam. Horm. 65: 97-126.
133. Feldkamp, T., J. M. Weinberg, M. Hörbelt, C. von Kropff, O. Witzke, J. Nürnberger, and A. Kribben. 2009. Evidence for involvement of nonesterified fatty acid protonophoric uncoupling during mitochondrial dysfunction caused by hypoxia and reoxygenation. Nephrol. Dial. Transplant. 24: 43-51.
134. Cole, M. A., A. J. Murray, L. E. Cochlin, L. C. Heather, S. McAleese, N. S. Knight, E. Sutton, A. A. Jamil, N. Parassol, and K. Clarke. 2011. A high fat diet increases mitochondrial fatty acid oxidation and uncoupling to decrease efficiency in rat heart. Basic Res. Cardiol. 106: 447-457.
135. Schönfeld, P., L. Schild, and W. Kunz. 1989. Long-chain fatty acids act as protonophoric uncouplers of oxidative phosphorylation in rat liver mitochondria. Biochim. Biophys. Acta. 977: 266-272.
136. Shabalina, I. G., W. C. Backlund, J. Bar-Tana, B. Cannon, and J. Nedergaard. 2008. Within brown-fat cells, UCP1-mediated fatty acid-induced uncoupling is independent of fatty acid metabolism. Biochim. Biophys. Acta. 1777: 642-650.
137. Walter, A., and J. Gutknecht. 1984. Monocarboxylic permeation through lipid bilayer membrane. J. Membr. Biol. 77: 255-264.
138. Woldegiorgis, G., E. Shrago, J. Gipp, and M. Yatvin. 1981. Fatty acyl coenzyme A-sensitive adenine nucleotide transport in a reconstituted liposome system. J. Biol. Chem. 256: 12297-12300.
139. Rabkin, M., and J. J. Blum. 1985. Quantitative analysis of intermediary metabolism in hepatocytes incubated in the presence and absence of glucagon with a substrate mixture containing glucose, ribose, fructose, alanine and acetate. Biochem. J. 225: 761-786.
140. Crabtree, B., M. J. Souter, and S. E. Anderson. 1989. Evidence that the production of acetate in rat hepatocytes is a predominantly cytoplasmic process. Biochem. J. 257: 673-678.
141. Crabtree, B., M. J. Gordon, and S. L. Christie. 1990. Measurement of the rates of acetyl-CoA hydrolysis and synthesis from acetate in rat hepatocytes and the role of these fluxes in substrate cycling. Biochem. J. 270: 219-225.
142. Akerboom, T. P. M., H. Bookelman, P. F. Zuurendonk, R. van den Meer, and J. M. Tager. 1978. Intramitochondrial and extramitochondrial concentrations of adenine nucleotides and inorganic phosphate in isolated hepatocytes from fasted rats. Eur. J. Biochem. 84: 413-420.
143. Otto, D. A. 1984. Relationship of the ATP/ADP ratio to the site of octanoate activation. J. Biol. Chem. 259: 5490-5494.
144. Lutz, W. H., T. P. Geisbuhler, J. D. Pollack, H. J. McClung, and A. J. Merola. 1985. Inhibition of citrulline synthesis by octanoate and its modulation by adenine nucleotides. Biochem. Med. 34: 1-10.
145. Schönfeld, P., and R. Bohnensack. 1991. Intramitochondrial fatty acid activation enhances control strength of the adenine nucleotide translocase. Biomed. Biochim. Acta. 50: 841-849.
146. Baba, N., E. F. Bracco, and S. A. Hashim. 1982. Enhanced thermogenesis and diminished deposition of fat in response to overfeeding with diet containing medium chain triglyceride. Am. J. Clin. Nutr. 35: 678-682.
147. St-Onge, M. P., R. Ross, W. D. Parsons, and P. J. H. Jones. 2003. Medium-chain triglycerides increase energy expenditure and decrease adiposity in overweight men. Obes. Res. 11: 395-402.
148. St-Onge, M. P., and A. Bosarge. 2008. Weight-loss diet that includes consumption of medium-chain triacylglycerol oil leads to a greater rate of weight and fat mass loss than does olive oil. Am. J. Clin. Nutr. 87: 621-626.
149. Montgomery, M. K., B. Osborne, S. H. Brown, L. Small, T. W. Mitchell, G. J. Cooney, and N. Turner. 2013. Contrasting metabolic effects of medium- versus long-chain fatty acids in skeletal muscle. J. Lipid Res. 54: 3322-3333.
150. Hoeks, J., M. Mensink, M. K. C. Hesselink, K. Ekroos, and P. Schrauwen. 2012. Long- and medium-chain fatty acids induce insulin resistance to a similar extent in humans despite marked differences in muscle fat accumulation. J. Clin. Endocrinol. Metab. 97: 208-216.
151. Corkey, B. E., D. E. Hale, M. C. Glennon, R. I. Kelley, P. M. Coates, L. Kilpatrick, and C. A. Stanley. 1988. Relationship between unusual hepatic acyl coenzyme A profiles and the pathogenesis of Reye syndrome. J. Clin. Invest. 82: 782-788.
152. Sauer, S. W., J. G. Okub, G. F. Hoffmann, S. Koelker, and M. A. Morath. 2008. Impact of short- and medium-chain organic acids, acylcarnitines, and acyl-CoAs on mitochondrial energy metabolism. Biochim. Biophys. Acta. 1777: 1276-1282.
153. St-Pierre, J., J. A. Buckingham, S. J. Roebuck, and M. D. Brand. 2002. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J. Biol. Chem. 277: 44784-44790.
154. Hoffman, D. L., and P. S. Brookes. 2009. Oxygen sensitivity of mitochondrial reactive oxygen species generation depends on metabolic conditions. J. Biol. Chem. 284: 16236-16245.
155. Seifert, E. L., C. Estey, J. Y. Xuan, and M. E. Harper. 2010. Electron transport chain-dependent and independent mechanisms of mitochondrial H2 O2 emission during long-chain fatty acid oxidation. J. Biol. Chem. 285: 5748-5758.
156. Schönfeld, P., M. R. Wiȩckowski, M. Lebiedzińska, and L. Wojtczak. 2010. Mitochondrial fatty acid oxidation and oxidative stress: Lack of reverse electron transfer-associated production of reactive oxygen species. Biochim. Biophys. Acta. 1797: 929-938.
157. Perevoshchikova, I. V., C. L. Quinlan, A. L. Orr, A. A. Gerencser, and M. D. Brand. 2013. Sites of superoxide and hydrogen peroxide production during fatty acid oxidation in rat skeletal muscle mitochondria. Free Radic. Biol. Med. 61: 298-309.
158. Schönfeld, P., and L. Wojtczak. 2012. Brown adipose tissue mitochondria oxidizing fatty acids generate high levels of reactive oxygen species irrespective of the uncoupling protein-1 activity state. Biochim. Biophys. Acta. 1817: 410-418.
159. Murray, A. J., N. S. Knight, S. E. Little, L. E. Cochlin, M. Clements, and K. Clarke. 2011. Dietary long-chain, but not medium-chain triglycerides, impair exercise performance and uncouple cardiac mitochondria in rats. Nutr. Metab. (Lond). 8: 55.
160. Schönfeld, P., and L. Wojtczak. 2008. Fatty acids as modulators of the cellular production of reactive oxygen species. Free Radic. Biol. Med. 45: 231-241.
161. Schuck, P. F., G. C. Ferreira, A. P. Moura, E. N. B. Busanello, A. M. Tonin, C. S. Dutra-Filho, and M. Wajner. 2009. Medium-chain fatty acids accumulating in MCAD deficiency elicit lipid and protein oxidative damage and decrease non-enzymatic antioxidant defenses in rat brain. Neurochem. Int. 54: 519-525.